Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.390
0.00 (0.00%)
Apr 29, 2026, 9:47 AM EDT - Market open
Cocrystal Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 19 | 13 | 21 | 18 | 16 | 63 | |
| Market Cap Growth | 53.30% | -34.34% | 17.29% | 10.34% | -74.94% | -32.06% | |
| Enterprise Value | 14 | 7 | 9 | -12 | -26 | 2 | |
| Last Close Price | 1.39 | 0.98 | 2.02 | 1.72 | 1.95 | 7.80 | |
| PB Ratio | 3.03 | 2.13 | 2.16 | 0.66 | 0.40 | 0.82 | |
| P/TBV Ratio | 3.03 | 2.13 | 2.16 | 0.66 | 0.40 | 1.08 | |
| Debt / Equity Ratio | 0.24 | 0.24 | 0.19 | 0.07 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.87 | -0.87 | -0.85 | -0.93 | -0.93 | -0.75 | |
| Net Debt / EBITDA Ratio | 0.62 | 0.62 | 0.45 | 1.17 | 2.05 | 4.15 | |
| Net Debt / FCF Ratio | 0.67 | 0.67 | 0.49 | 1.66 | 1.71 | 4.56 | |
| Quick Ratio | 3.50 | 3.50 | 4.56 | 8.35 | 31.14 | 38.00 | |
| Current Ratio | 3.68 | 3.68 | 4.77 | 8.92 | 33.04 | 38.40 | |
| Return on Equity (ROE) | -111.40% | -111.40% | -97.50% | -54.54% | -66.32% | -21.81% | |
| Return on Assets (ROA) | -48.66% | -48.66% | -49.98% | -36.68% | -18.86% | -13.30% | |
| Return on Capital Employed (ROCE) | -120.20% | -120.20% | -162.10% | -75.60% | -45.80% | -18.30% | |
| Earnings Yield | -46.09% | -65.44% | -85.17% | -102.64% | -244.58% | -22.39% | |
| FCF Yield | -42.81% | -60.80% | -80.25% | -84.38% | -135.46% | -20.16% | |
| Buyback Yield / Dilution | -10.97% | -10.97% | -5.42% | -18.52% | -10.58% | -60.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.